Cargando…
Diclofenac: A Nonsteroidal Anti-Inflammatory Drug Inducing Cancer Cell Death by Inhibiting Microtubule Polymerization and Autophagy Flux
Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) used to treat inflammatory diseases induces cellular toxicity by increasing the production of reactive oxygen species (ROS) and impairing autophagic flux. In this study, we investigated whether diclofenac induces cancer cell death and the mec...
Autores principales: | Choi, Soohee, Kim, Suree, Park, Jiyoung, Lee, Seung Eun, Kim, Chaewon, Kang, Dongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138099/ https://www.ncbi.nlm.nih.gov/pubmed/35624874 http://dx.doi.org/10.3390/antiox11051009 |
Ejemplares similares
-
Quantitative and qualitative analysis of autophagy flux using imaging
por: Kim, Suree, et al.
Publicado: (2020) -
Diclofenac impairs autophagic flux via oxidative stress and lysosomal dysfunction: Implications for hepatotoxicity
por: Jung, Seung-Hwan, et al.
Publicado: (2020) -
Diclofenac, a nonsteroidal anti‐inflammatory drug, is an antagonist of human TRPM3 isoforms
por: Suzuki, Hiroka, et al.
Publicado: (2016) -
Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch
por: Lionberger, David R, et al.
Publicado: (2010) -
Autophagy: novel applications of nonsteroidal anti‐inflammatory drugs for primary cancer
por: Yu, Chen, et al.
Publicado: (2017)